Decade-long temporal trends in the utilization of preventive medicines by centenarians

Journal of Clinical Pharmacy and Therapeutics

Volumn 42, Issue 2, 2017, Pages 165-169

  Narayan, S W ^a   Nishtala, P S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

antithrombotics; bisphosphonates; centenarians; older people; preventive medicines; statins

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; ATORVASTATIN; BISPHOSPHONIC ACID DERIVATIVE; CLOPIDOGREL; DABIGATRAN; ETIDRONIC ACID; EZETIMIBE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; RISEDRONIC ACID; SIMVASTATIN; WARFARIN; ZOLEDRONIC ACID; ANTICOAGULANT AGENT; TICLOPIDINE;

AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; LOW DRUG DOSE; MALE; NEW ZEALAND; PRESCRIPTION; PREVENTIVE MEDICINE; TREND STUDY; VERY ELDERLY; ANALOGS AND DERIVATIVES; DRUG UTILIZATION; TRENDS;

AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PREVENTIVE MEDICINE; TICLOPIDINE;

EID: 85006836371     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12487     Document Type: Article

References (40)

1. Kakar P. Preventive medicine in the older patient: a United Kingdom perspective. Int J Prev Med, 2012;3:379–385.
2. Willcox DC, Willcox BJ, Poon LW. Centenarian studies: important contributors to our understanding of the aging process and longevity. Curr Gerontol Geriatr Res, 2010;2010:484529.
3. Wastesson JW, Parker MG, Fastbom J, Thorslund M, Johnell K. Drug use in centenarians compared with nonagenarians and octogenarians in Sweden: a nationwide register-based study. Age Ageing, 2012;41:218–224.
4. The New England Centenarian Study. Why Study Centenarians: An Overview. Available at: http://www.bumc.bu.edu/centenarian/ (accessed 21 July 2016).
5. Okinawa Centenarian Study. Available at: http://www.okicent.org/cent.html (accessed 19 July 2016).
6. Perls TT, Bochen K, Freeman M, Alpert L, Silver MH. Validity of reported age and centenarian prevalence in New England. Age Ageing, 1999;28:193–197.
7. Narayan SW, Tordoff JM, Nishtala PS. Temporal trends in the utilisation of preventive medicines by older people: a 9-year population-based study. Arch Gerontol Geriatr, 2016;62:103–111.
8. Cooper GS, Goodwin MA, Stange KC. The delivery of preventive services for patient symptoms. Am J Prev Med, 2001;21:177–181.
9. Miettinen OS. Reflections on preventive medicine. Prev Med, 2014;67:313–315.
10. Narayan SW, Nishtala PS. Prevalence of potentially inappropriate medicine use in older New Zealanders: a population-level study using the updated 2012 Beers criteria. J Eval Clin Pract, 2015;21:633–641.
11. Narayan SW, Nishtala PS. Antihypertensive medicines utilization: a decade-long nationwide study of octogenarians, nonagenarians and centenarians. Geriatr Gerontol Int, 2016. doi:10.1111/ggi.12838.
12. Naples JG, Hanlon JT, Schmader KE, Semla TP. Recent literature on medication errors and adverse drug events in older adults. J Am Geriatr Soc, 2016;64:401–408.
13. Hazra NC, Dregan A, Jackson S, Gulliford MC. Drug utilization and inappropriate prescribing in centenarians. J Am Geriatr Soc, 2016;64:1079–1084.
14. Schweitzer SO, Atchison KA, Lubben JE, Mayer-Oakes SA, De Jong FJ, Matthias RE. Health promotion and disease prevention for older adults: opportunity for change or preaching to the converted? Am J Prev Med, 1994;10:223–229.
15. Smith NL, Psaty BM, Furberg CD et al. Temporal trends in the use of anticoagulants among older adults with atrial fibrillation. Arch Intern Med, 1999;159:1574–1578.
16. Sumukadas D, McMurdo MET, Mangoni AA, Guthrie B. Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data. Age Ageing, 2014;43:515–521.
17. Nishtala PS, Salahudeen MS. Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005–2013. Gerontology, 2015;61:195–202.
18. Basger BJ, Chen TF, Moles RJ. Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method. BMJ Open, 2012;2:1–20.
19. Richmond RL, Law J, KayLambkin F. Morbidity profiles and lifetime health of Australian centenarians. Australas J Ageing, 2012;31:227–232.
20. Lepa T, Norris P, Horsburgh S, Taungapeau F. Accuracy of National Health Index numbers for Pacific people in NZ. Aust N Z J Public Health, 2013;37:189–190.
21. Ali A, Katz DL. Disease prevention and health promotion. Am J Prev Med, 2015;49:S230–S240. doi:10.1016/j.amepre.2015.07.019.
22. The New Zealand Formulary. Available at: http://nzformulary.org/ (accessed 22 July 2016).
23. Kozma CM, Dickson M, Phillips AL, Meletiche DM. Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis. Patient Prefer Adherence, 2013;7:509–516.
24. Hazra NC, Dregan A, Jackson S, Gulliford MC. Differences in health at age 100 according to sex: population-based cohort study of centenarians using electronic health records. J Am Geriatr Soc, 2015;63:1331–1337.
25. Sivenius J, Riekkinen PJ Sr, Laakso M. Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes. BMJ, 1995;310:25–26.
26. Silagy CA, McNeil JJ, Donnan GA, Tonkin AM, Worsam B, Campion K. Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther, 1993;54:84–89.
27. Agüero-Torres H, Viitanen M, Fratiglioni L, Louhija J. The effect of low-dose daily aspirin intake on survival in the Finnish centenarians cohort. J Am Geriatr Soc, 2001;49:1578–1580.
28. De Berardis G, Lucisano G, D'Ettorre A et al. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA, 2012;307:2286–2294.
29. Bajorek B. A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks. Ther Adv Drug Saf, 2011;2:45–58.
30. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD. Hypercoagulability in centenarians: the paradox of successful aging. Blood, 1995;85:3144–3149.
31. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in Atrial Fibrillation (ATRIA) Study. JAMA, 2001;285:2370–2375.
32. Kerr CR, Humphries K. Gender-related differences in atrial fibrillation. J Am Coll Cardiol, 2005;46:1307–1308.
33. Nishtala PS, Gnjidic D, Jamieson HA, Hanger HC, Kaluarachchi C, Hilmer SN. ‘Real-world’ haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand. Int J Cardiol, 2016;203:746–752.
34. San-Jose A, Agusti A, Vidal X et al. Inappropriate prescribing to the oldest old patients admitted to hospital: prevalence, most frequently used medicines, and associated factors. BMC Geriatr, 2015;15:1–9.
35. Strandberg TE, Kolehmainen L, Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia: a clinical review. JAMA, 2014;312:1136–1144.
36. Stone NJ, Robinson JG, Lichtenstein AH et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2014;63:2889–2934.
37. Taylor F, Ward K, Moore TH et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev, 2011;(1):CD004816.
38. Wysowski DK, Greene P. Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002–2012. Bone, 2013;57:423–428.
39. Gnjidic D, Le Couteur DG, Pearson SA et al. High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health, 2013;13:1–9.
40. Prescription Charges. Ministry of Health. Available at: http://www.health.govt.nz/your-health/conditions-and-treatments/treatments-and-surgery/medications/prescription-charges (accessed 22 July 2016).